Navigation Links
Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322

to evaluating CT-322 in Phase 2 later this year."

CT-322 is currently in Phase 1 clinical development in oncology in the United States, and in February 2007 Adnexus announced interim results of an ongoing Phase 1 open-label, dose-escalation study in patients with advanced cancers. In those interim results, CT-322 demonstrated promising evidence of biological activity in patients within four hours of drug administration as evidenced by elevated plasma levels of biomarkers associated with blockade of VEGFR-2. These biomarkers remained elevated significantly above baseline throughout the treatment period. In addition, CT-322 administration resulted in predictable, consistent pharmacokinetics that could support every-other-week dosing in humans.

Abstract Number: 4189

About the Adnectin Product Class and the PROfusion System

Adnectins are an emerging protein therapeutic class that can be designed to treat a broad range of diseases. They are based on human fibronectin, an extracellular protein that is naturally abundant in human serum. The intrinsic properties of an Adnectin align with properties of successful drugs, including high potency, specificity, stability, favorable half life, favorable IP profile and high yield E. coli production.

Adnectins are designed using the PROfusion System, Adnexus' patented protein design engine, to achieve high potency and specificity for a therapeutic target while simultaneously selecting for ideal pharmaceutical product characteristics. PROfusion enables Adnexus to screen over 1 trillion unique Adnectins for each drug discovery program to "redirect" naturally occurring human fibronectin to act as a protein therapeutic. This greatly accelerates Adnectin drug discovery and development.

Adnexus is the exclusive developer of Adnectins. Adnexus solely owns the Adnectin patent estate that controls issued and pending patent properties to fundamental Adnectin forms. In addition, Adnexus exclusively co
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care

Post Your Comments:
(Date:11/28/2009)...re/ -- Siemens Healthcare redefines productivity ...aging matrix) technology and with its new Dot(TM) ...ies are introduced in the new MAGNETOM ® Aer...anners at the 95th Scientific Assembly and Annual ...ca (RSNA) from November 29 to December 3 at McCorm...
(Date:11/27/2009)...wire/ -- At the upcoming Radiological Society of N..., Royal Philips Electronics ( PHG, AEX: PHI) will ...informatics solutions designed to directly address... delivering meaningful imaging innovations that re... easy upgradability. This focus will enable Phili...
(Date:11/25/2009)... Heska Corporation ( HSKA...gnostic and specialty products to the veterinary i...gnostics Corporation for the supply of blood gas p...ary market. ,, (Logo: http://www.newscom.c...and Roche share the same passion for innovating in...
Breaking Medicine Technology:Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3IOF AMGEN Health Professional Awareness Grants awarded at Beijing conference 10092 1IOF AMGEN Health Professional Awareness Grants awarded at Beijing conference 10092 2Forest Service Web based tool helps manage environmental risk 10090 1Forest Service Web based tool helps manage environmental risk 10090 2NIH announces 115 awards to encourage high risk research and innovation 10088 1NIH announces 115 awards to encourage high risk research and innovation 10088 2
...LES, Feb. 5 New polymer material designed to,stop...ical infection,according to a new animal study to ...l Orthopaedics and Related Research (CORR). The st...ital-acquired infections,including MRSA., Researc... at Charleston,and Keck School of Medicine at the ...
... N.J., Feb. 4 This week, Summit VetPharm has,iden...e Vectra 3D(TM),product has been found on the webs...lation of the Company,s anti-diversion policy., "...ully violated our,anti- diversion contract and pla... sale," stated Julia Stephanus, president and CEO ...
Other Medicine Technology:Ceremed's OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds 2Ceremed's OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds 3Summit VetPharm has Identified Two Instances of Diverted Vectra 3D(TM) 2Summit VetPharm has Identified Two Instances of Diverted Vectra 3D(TM) 3
(Date:11/28/2009)... to help lift spirits, recognize signs of depressi...) -- For many seniors, the holiday season can trig..., struggle with health issues or worry about money...ciety. , To help overcome the seasonal blues, t...ollowing advice: , Get out and socialize or invi...
(Date:11/27/2009)...NCISCO, Nov. 27 The Gymb...lair Lambert, CFO/COO, will present at the NASDAQ ...he May Fair Hotel in London, England, on Wednesday...sten to a live broadcast of The Gymboree Corporati... to www.gymboree.com, click on "Our Company" at th...
(Date:11/27/2009)...g plus low-emission vehicles may reduce future dis... Nov. 27 (HealthDay News) -- Encouraging city dwel...ld offer much greater public health benefits than ...archers have found. , The study compared the pr...n land transport scenarios for London, England, an...
(Date:11/27/2009)... Specialist manufacturers who use medical l...g millions of dollars by bringing in technology pa...ing numbers of pro-active medical manufacturers ar...ept stage of their projects, ensuring that progres...sses or potentially outdated technology. , ...
(Date:11/26/2009)...stering drug tetrathiomolybdate (TM) has been show...ilson disease, a disease caused by an overload of ...is known. Very little, however, is known about how...study led by Northwestern University researchers n...nsional structure of TM bound to copper-loaded met...
Breaking Medicine News(10 mins):Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
... Southwestern Medical Center have discovered a pro...cks microbial invaders and protects the// intestin... in enabling patient’s suffering inflammatory bowe...em. Scientists have known for decades that ...
... has indicated India's stance on Poultry imports, ...h period. Poultry products, live poultry and impor...reas vulnerable to bird-flu outbreak. The ...birds. India has also laid an embargo on import fr...
...years, the number of cervical cancer deaths in the... a year. The main reason for the decrease is the P...ical cancer prevention has entered a new era, with... cancers. Although the vaccine promises to save li...
...that require limiting of the amount of coal dust i...' or pneumoconiosis, according to a report from// ... The Coal Workers' Health Surveillance Program h...port by Dr. V. C. Antao and his associates in the ...
...mber at a Sydney maternity hospital was diagnosed ... families may have to be given antibiotics// as a ...at the women and babies facility of Royal Prince A...l contact with patients and families immediately,'...
...o Clinic estimates that about 5 million adult Amer...as a consequence of aging, according to a Mayo Cli...While rheumatic fever was previously the main caus...ry today, thanks to antibiotic therapy and improve...
Other Medicine News:Health News:Protective Intestinal Antibiotic Protein Discovered 2Health News:US Miners Still Prey to Black lung Disease 2Health News:Valve Disease Study Suggests New Public Health Concern 2Health News:Valve Disease Study Suggests New Public Health Concern 3
Acri.Sil-oI 1000
Ispan SF6 Intraocular Gases
Silikon 1000 Silicone Oil
Foreign body spud
Medicine Products: